Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
Rheumatol Int ; 44(6): 1155-1163, 2024 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-38678142

RESUMEN

To assess the incidence and prevalence of rheumatoid arthritis (RA) in Poland for the period 2013-2021, total and dependent on gender, age, region and serological status. Information on reported National Health Fund (NHF) health services and reimbursed prescriptions were used, defining an RA patient as a person who had at least two visits in different quarters with ICD-10 code M05 or M06 and at the same time filled at least one reimbursed prescription for a drug whose active substance is methotrexate, sulfasalazine, leflunomide or was treated with biologic disease-modifying anti-rheumatic drugs (bDMRDs) or targeted synthetic DMARDs (tsDMARDs) as part of a drug program financed by the National Health Fund. The nationwide standardised incidence rate of RA in 2021 was 29 persons per 100,000 population (18 per 100,000 population of seropositive vs. 11 per 100,000 population of seronegative RA). The prevalence of RA in Poland in 2021 was 689.0 people per 100,000 population, a total of 0.7% (1.1% in women and 0.3% in men). The incidence of seronegative RA was approximately 38%. The majority of new RA diagnoses were in the sixth and seventh decades of life, irrespective of patients' gender. The results allow RA to be classified as a disease with a significant social impact. A trend of later onset of RA has been observed, which requires special consideration of the needs of patients over 55 years of age.


Asunto(s)
Antirreumáticos , Artritis Reumatoide , Humanos , Polonia/epidemiología , Artritis Reumatoide/epidemiología , Artritis Reumatoide/tratamiento farmacológico , Artritis Reumatoide/diagnóstico , Masculino , Femenino , Incidencia , Persona de Mediana Edad , Adulto , Anciano , Prevalencia , Adolescente , Adulto Joven , Antirreumáticos/uso terapéutico , Distribución por Edad , Distribución por Sexo , Niño , Preescolar , Anciano de 80 o más Años , Lactante
2.
Int J Food Microbiol ; 211: 134-41, 2015 Oct 15.
Artículo en Inglés | MEDLINE | ID: mdl-26204235

RESUMEN

To assess the occurrence of antibiotic-resistant Lactic Acid Bacteria (LAB) in Polish raw milk and fermented artisanal products, a collection comprising 500 isolates from these products was screened. Among these isolates, six strains (IBB28, IBB160, IBB161, IBB224, IBB477 and IBB487) resistant to tetracycline were identified. The strains showing atypical tetracycline resistance were classified as Lactococcus lactis: three of them were identified as L. lactis subsp. cremoris (IBB224, IBB477 and IBB487) and the other three (IBB28, IBB160, IBB161) were identified as L. lactis subsp. lactis. The mechanism involving Ribosomal Protection Proteins (RPP) was identified as responsible for tetracycline resistance. Three of the tested strains (IBB28, IBB160 and IBB224) had genes encoding the TetS protein, whereas the remaining three (IBB161, IBB477 and IBB487) expressed TetM. The results also demonstrated that the genes encoding these proteins were located on genetic mobile elements. The tet(S) gene was found to be located on plasmids, whereas tet(M) was found within the Tn916 transposon.


Asunto(s)
Antibacterianos/farmacología , Productos Lácteos/microbiología , Lactococcus lactis/efectos de los fármacos , Lactococcus lactis/aislamiento & purificación , Leche/microbiología , Resistencia a la Tetraciclina , Tetraciclina/farmacología , Animales , Reactores Biológicos/microbiología , Fermentación , Lactococcus lactis/genética , Plásmidos/efectos de los fármacos , Polonia
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA